
Lifecome
002868.SZLifecome Biochemistry Co.,Ltd. Price (002868.SZ)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
154,040,193
(0.4145)%Revenue and Profitability
Year | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 306,555,594 | 297,150,634 | 295,776,106 | 385,613,322 | 401,490,366 | 375,411,280 | 344,291,893 | 303,759,977 | 308,145,259 | 363,386,382 | 329,850,238 | 507,004,856 |
Net Income | 43,240,615 | 32,970,233 | 31,449,370 | 78,104,645 | 92,360,698 | 85,924,989 | 74,689,446 | 56,966,032 | 43,208,315 | -26,444,133 | -122,721,550 | -221,817,878 |
FCF USD | 11,664,367 | 20,680,512 | 38,097,897 | 87,456,919 | 120,585,418 | 77,544,704 | 34,764,398 | -51,513,666 | -163,069,327 | -321,996,649 | -146,153,636 | -651,297,958 |
OCF USD | 60,915,165 | 77,678,720 | 62,759,716 | 127,107,974 | 135,407,947 | 96,109,559 | 83,697,141 | 74,087,742 | 90,720,874 | 35,170,418 | -8,833,006 | -186,758,867 |
Financial Health - DEBT
Year | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
YTPD | 0.00 | 0.26 | 0.85 | 0.19 | 0.03 | 0.00 | 0.00 | 1.35 | 1.33 | -3.67 | -1.23 | -2.37 |
D/E | 0.64 | 0.74 | 0.75 | 0.35 | 0.12 | 0.00 | 0.00 | 0.16 | 0.11 | 0.43 | 0.60 | 2.34 |
CA/CL | 0.70 | 0.57 | 0.59 | 0.73 | 1.13 | 9.75 | 9.43 | 4.26 | 2.40 | 0.58 | 1.04 | 0.51 |
TA/TL | 1.73 | 1.75 | 1.96 | 2.56 | 3.73 | 12.49 | 12.93 | 4.36 | 4.80 | 2.35 | 1.94 | 1.27 |
Total Debt | 100,235,650 | 125,431,655 | 142,495,172 | 83,306,704 | 33,214,722 | 1,216,763 | 0 | 121,838,128 | 82,075,854 | 307,668,184 | 357,257,597 | 962,725,444 |
Management Performance
Year | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
ROIC | 13.40% | 7.13% | 8.25% | 22.37% | 28.24% | 12.20% | 9.96% | 6.29% | 5.00% | -1.70% | -13.20% | -14.84% |
ROE | 27.64% | 19.46% | 16.48% | 32.68% | 34.04% | 12.35% | 10.09% | 7.36% | 5.65% | -3.68% | -20.60% | -53.93% |
ROA | 0.00% | 8.33% | 8.06% | 19.90% | 24.92% | 11.36% | 9.31% | 5.63% | 4.41% | -2.10% | -9.90% | -11.33% |
NM % | 14.11% | 11.10% | 10.63% | 20.25% | 23.00% | 22.89% | 21.69% | 18.75% | 14.02% | -7.28% | -37.21% | -43.75% |
FCF / R% | 0.00% | 6.96% | 12.88% | 22.68% | 30.03% | 20.66% | 10.10% | -16.96% | -52.92% | -88.61% | -44.31% | -128.46% |
FCF / NI% | 26.98% | 62.72% | 121.14% | 111.97% | 130.56% | 90.25% | 46.55% | -90.64% | -379.80% | 1,217.65% | 119.09% | 292.56% |
Operating Margin (OM) | 0.00 | 0.12 | 0.18 | 0.24 | 0.29 | 0.44 | 0.58 | 0.74 | 0.79 | 0.54 | 0.23 | -0.29 |
Per Share
Year | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS | 0.37 | 0.28 | 0.27 | 0.67 | 0.79 | 0.60 | 0.48 | 0.37 | 0.28 | -0.17 | -0.80 | -1.44 |
SPS | 2.62 | 2.57 | 2.53 | 3.30 | 3.44 | 2.62 | 2.21 | 1.95 | 2.01 | 2.37 | 2.15 | 3.29 |
OCPS | 0.52 | 0.67 | 0.54 | 1.09 | 1.16 | 0.67 | 0.54 | 0.47 | 0.59 | 0.23 | -0.06 | -1.21 |
FCPS | 0.10 | 0.18 | 0.33 | 0.75 | 1.03 | 0.54 | 0.22 | -0.33 | -1.06 | -2.10 | -0.95 | -4.23 |
BVPS | 1.34 | 1.46 | 1.63 | 2.05 | 2.33 | 4.86 | 4.75 | 4.99 | 5.02 | 4.71 | 3.91 | 2.69 |
Per Share - CAGR
Year | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
CAGR-EPS | 0.37 | 0.28 | 0.27 | 0.67 | 0.79 | 0.60 | 0.48 | 0.37 | 0.28 | -0.17 | -0.80 | -1.44 |
CAGR-SPS | 2.62 | 2.57 | 2.53 | 3.30 | 3.44 | 2.62 | 2.21 | 1.95 | 2.01 | 2.37 | 2.15 | 3.29 |
CAGR-OCPS | 0.52 | 0.67 | 0.54 | 1.09 | 1.16 | 0.67 | 0.54 | 0.47 | 0.59 | 0.23 | -0.06 | -1.21 |
CAGR-FCPS | 0.10 | 0.18 | 0.33 | 0.75 | 1.03 | 0.54 | 0.22 | -0.33 | -1.06 | -2.10 | -0.95 | -4.23 |
CAGR-BVPS | 1.34 | 1.46 | 1.63 | 2.05 | 2.33 | 4.86 | 4.75 | 4.99 | 5.02 | 4.71 | 3.91 | 2.69 |